Bayer’s second quarter earnings are down, largely because of costs associated with settling lawsuits from consumers who claim the pharmaceutical giant’s Yasmin line of birth control pills caused health problems, the Pittsburgh Post Gazette reports.
Despite the lagging profits, however, the company said global sales for the quarter jumped by 10 percent to a record $12.5 billion on strong performances by all three of the company’s business segments. Crop sciences revenues ...
continue reading...